Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insight Molecular Diagnostics (IMDX) Goodwill & Intangibles (2020 - 2025)

Insight Molecular Diagnostics' Goodwill & Intangibles history spans 6 years, with the latest figure at $14.6 million for Q1 2025.

  • For Q1 2025, Goodwill & Intangibles fell 74.36% year-over-year to $14.6 million; the TTM value through Mar 2025 reached $14.6 million, down 74.36%, while the annual FY2024 figure was $14.6 million, 74.35% down from the prior year.
  • Goodwill & Intangibles for Q1 2025 was $14.6 million at Insight Molecular Diagnostics, roughly flat from $14.6 million in the prior quarter.
  • Across five years, Goodwill & Intangibles topped out at $113.4 million in Q2 2022 and bottomed at $9.2 million in Q1 2021.
  • The 5-year median for Goodwill & Intangibles is $24.2 million (2021), against an average of $41.9 million.
  • The largest annual shift saw Goodwill & Intangibles surged 367.76% in 2022 before it plummeted 74.36% in 2025.
  • A 5-year view of Goodwill & Intangibles shows it stood at $80.4 million in 2021, then dropped by 23.03% to $61.9 million in 2022, then dropped by 8.0% to $56.9 million in 2023, then crashed by 74.35% to $14.6 million in 2024, then decreased by 0.05% to $14.6 million in 2025.
  • Per Business Quant, the three most recent readings for IMDX's Goodwill & Intangibles are $14.6 million (Q1 2025), $14.6 million (Q4 2024), and $56.9 million (Q1 2024).